ACELRX PHARMACEUTICALS INC - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - January 31, 2011

Attached files

file filename
S-1/A - AMENDMENT NO. 4 TO FORM S-1 - ACELRX PHARMACEUTICALS INCds1a.htm
EX-4.2 - SPECIMEN COMMON STOCK CERTIFICATE OF THE REGISTRANT - ACELRX PHARMACEUTICALS INCdex42.htm
EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - ACELRX PHARMACEUTICALS INCdex31.htm
EX-10.10 - NOTE AND WARRANT PURCHASE AGREEMENT - ACELRX PHARMACEUTICALS INCdex1010.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 30, 2010, except for the last paragraph of Note 1, as to which the date is January 28, 2011, in the Registration Statement (Amendment No. 3 to Form S-1) and related Prospectus of AcelRx Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

San Francisco, California

January 31, 2011

ACELRX PHARMACEUTICALS INC Reports

Also read